Fundraising FoxLifelink
Venture capitalBarcelona · Seed–Series A · 5 people tracked
Find your way into Lifelink
Sign up to see every warm intro you have to Lifelink
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lifelink team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
LifeLink Ventures aims to bridge private capital and emerging investment opportunities that address global health challenges. The firm invests in early-stage health and biotech companies and builds long-term relationships with founders, engaging with them early to understand their vision over time. It seeks urgently needed therapies developed by entrepreneurs and connects them with its network of private investors, framing capital deployment around the cause of improving global health. Based in Barcelona, Spain, the firm sources companies and works with investors across Europe and internationally.
Source: firm website, verified Oct 2, 2026.
Team · 5 people
from the firm's website
Founder mafia
2 people who came through Lifelink went on to found or lead other companies.
What they invest in
from 11 of 15 portfolio companiesBiotech ×11Healthtech ×7Medical Devices ×7AI & Machine Learning ×5Digital Health ×3Deep Tech ×2Longevity ×2
HQs:United States×5United Kingdom×2Switzerland×1
Who they back
founder profiles across 8 portfolio companiesFounding team size:solo founder×52 founders×3
Investments · 15 tracked
founders shown can be your intro pathAccure Health is a company focused on developing treatments to improve the lives of patients and their relatives affected by central nervous system (CNS) diseases.
BiotechHealthtech
Laurent Nguyen(Chief Executive Officer, Board member)inPablo Villoslada(CSO)inRossella Medori(CMO)inPaul Bikard(CFO)in
Co-investorsAliath BioventuresAsabys PartnersKinled HoldingAlta Life Sciences
Arda develops therapeutics using single-cell computational biology to target and eliminate pathogenic cells in chronic diseases.
AI & Machine LearningBiotechDigital HealthLongevityMedical DevicesAustin, US
Adam Freund(Founder & Chief Executive Officer)inRemi-Martin Laberge(Founder and Chief Technology Officer)in
BoardVineeta Agarwala(Director)in
Co-investorsage1Alumni VenturesAndreessen HorowitzGV (Google Ventures)Olima VenturesRV Invest GmbH+7 more
Crossbow Therapeutics develops TCR-mimetic antibody therapies designed to target cancer antigens by mimicking T-cell receptors, with a focus on treating solid tumors and hematologic malignancies.
AI & Machine LearningBiotechMedical DevicesCambridge, US
Alexander Nolte(Executive Officer)inDmitri Wiederschain(Executive Officer)in
BoardAlexandra Cantley(Director)inSakae Asanuma(Director)inBriggs Morrison(Executive Officer, Director, Promoter)inIrena Melnikova(Director)in
Co-investorsMPM BioImpactPfizer Venture InvestmentsBiotechnology Value FundMirae Asset Venture InvestmentPfizer VenturesPolaris Partners+1 more
Doctify is a UK-founded healthcare platform that collects and publishes verified patient reviews of clinicians and care providers.
Stephanie Eltz(Founder)in
Co-investorsAmadeus Capital PartnersBeringeaGuinness VenturesKeen Venture PartnersKinled HoldingAmadeus Capital SA
Eveliqure develops a live attenuated vaccine platform for oral administration targeting Shigella and ETEC pathogens that cause diarrheal disease in travelers and populations in low- and middle-income countries.
BiotechHealthtechMedical Devices
Tamás Henics(Co-Founder and Chief Scientific Officer)Gábor Somogyi(Chief Executive Officer)
Co-investorsKinled HoldingSmartWare.techSTRT
HAYA Therapeutics develops precision RNA medicines that target long non-coding RNAs (lncRNAs) in the regulatory genome to reprogram disease at the level of cell state, with a lead program in cardiac fibrosis and work in obesity and metabolic disease.
AI & Machine LearningBiotechDeep TechHealthtech
Samir Ounzain(Chief Executive Officer (CEO) & Co-founder)inDaniel Blessing(Chief Scientific Officer (CSO) & Co-founder)inRichard Law(Chief Business Officer (CBO))inEric Adam(Chief Operating Officer (COO))inJordan Shin(Chief Medical Officer (CMO))inJérôme Andries(Chief Financial Officer (CFO))in
Co-investorsBroadview VenturesSofinnova PartnersApollo Health Ventures+ND Capital4see VenturesHumboldt
Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies.
BiotechDigital HealthMedical DevicesWaltham, US
Amanda Wagner(Executive Officer)Dan Matloff(Executive Officer)Jiaping Gu(Director)Jeffrey Goldberg(Executive Officer, Director)
BoardLaura Brass(Director)inKai Wucherpfennig(Director)
Co-investorsAgent CapitalDC Investment PartnersLongwood FundMedical Excellence CapitalNovartis Venture FundOno Venture Investment, Inc.+5 more
InCephalo develops compartment-locked cytokine therapeutics that deliver localized immune activation to brain tumors while avoiding systemic exposure, with a lead asset targeting glioblastoma and other CNS diseases.
BiotechHealthtechMedical DevicesSchlieren, CH
Johannes vom Berg(CSO & Co-Founder)
Macomics is a drug discovery company developing therapies that target macrophage activity for diseases with limited or ineffective treatment options.
BiotechLongevity
Co-investorsEpidarex CapitalScottish Enterprise
Ochre Bio develops RNA therapeutics and drug discovery platforms targeting liver disease, combining proprietary human liver datasets with AI-driven causal prediction and human tissue validation models.
AI & Machine LearningBiotechHealthtechMedical DevicesLondon, GB
Quin Wills(CSO)inJack O'Meara(Founder)in
BoardChinwe UkomaduElaine SullivanEliot ForsterJack Castle
Co-investorsBackedBeast VenturesCoastCapEntrepreneur FirstExpaHoxton Ventures+18 more
Spiral Therapeutics is a clinical-stage pharmaceutical company developing therapies for balance disorders and hearing loss using its Minimally Invasive Cochlear System (MICS) drug delivery platform.
BiotechDigital HealthHealthtechMedical DevicesSouth San Francisco, US
Hugo Peris(Founder & CEO)inEugene de Juan(Executive Officer, Director)Lawrence Fritz(Director)
BoardWARREN THALER(Director)JEAN-FREDERIC PAULSEN(Director)Guy Nohra(Director)in
Co-investorsCatalio Capital ManagementInveready Technology Investment GroupStartXAlta PartnersCamden PartnersEsperante Ventures
AIRNA develops genetic medicines that use ADAR, a naturally occurring human protein, to precisely edit RNA and treat genetic diseases without permanently modifying DNA.
AI & Machine LearningBiotechDeep TechHealthtechStanford, US
Thorsten Stafforst(Chairman of the Board of Directors)inKris ElveruminTodd Bazemore(Chief Executive Officer)inJin (Billy) Li(Treasurer and Secretary)inPaul Vogel(Chief Executive Officer and President)in
BoardRodger Novak(Chair)in
Co-investors+ND CapitalARCH Venture PartnersForbionVenrockFast Track InitiativeNextech Invest+3 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AlevaCalyxhaCebina
Portfolio news
latest coverage across their companiesSpiral Therapeutics · finsmes.com · Apr 14, 2026
Frequently asked questions
- How many investments has Lifelink made?
- Lifelink has 15 tracked investments.
- What stage does Lifelink invest at?
- Lifelink invests at the Seed, Series A stages.
- What sectors does Lifelink focus on?
- Lifelink focuses on Biotech, Digital Health, Healthtech.
- Where is Lifelink located?
- Lifelink is headquartered in Barcelona, ES.
- Who does Lifelink co-invest with?
- Lifelink most often shares deals with Kinled Holding, Gaingels, +ND Capital, among 47 tracked co-investors.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Bessemer Venture Partners is a global venture capital firm that partners with entrepreneurs across enterprise, consumer, and healthcare sectors from early stages through growth.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.